UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) May 3, 2017
Cross Country Healthcare, Inc.
(Exact
name of registrant as specified in its charter)
| Delaware | 0-33169 | 13-4066229 |
|
(State or Other Jurisdiction |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
5201 Congress Avenue, Suite 100B, Boca Raton, FL 33487
(Address
of Principal Executive Office) (Zip Code)
(561) 998-2232
(Registrant’s
telephone number, including area code)
(Former name or former
address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Section 2 – Financial Information
Item 2.02 Results of Operations and Financial Condition
(a) On May 3, 2017, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended March 31, 2017, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section.
Section 7 – Regulation FD
Item 7.01 Regulation FD Disclosure
Incorporated by reference is a press release issued by the Company on May 3, 2017, which is attached hereto as Exhibit 99.1. This information is being furnished under Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit | Description | ||
| 99.1 | Press Release issued by the Company on May 3, 2017 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
CROSS COUNTRY HEALTHCARE, INC. |
|||
|
|
By: |
/s/ William J. Burns |
|
|
|
William J. Burns |
||
|
|
EVP & Chief Financial Officer |
||
|
Dated: |
May 3, 2017 |
||
Exhibit 99.1
Cross Country Healthcare Announces First Quarter 2017 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--May 3, 2017--Cross Country Healthcare, Inc. (Nasdaq: CCRN) today announced financial results for the first quarter ended March 31, 2017.
FINANCIAL HIGHLIGHTS:
Amounts are in thousands, except percent and per share data.
| Q1 2017 |
Increase |
Increase |
||||||||||||||
| Revenue | $ | 207,573 | 6 | % | (7 | )% | ||||||||||
| Gross profit margin | 25.7 | % | (30 | )bps | (20 | )bps | ||||||||||
| Net (loss) income attributable to common shareholders | $ | (2,010 | ) | (111 | )% | 75 | % | |||||||||
| Diluted EPS | $ | (0.08 | ) | $ | (0.17 | ) | $ | 0.16 | ||||||||
| Adjusted EBITDA* | $ | 6,453 | (24 | )% | (46 | )% | ||||||||||
| Adjusted EPS* | $ | 0.05 | $ | (0.04 | ) | $ | (0.15 | ) | ||||||||
* Refer to tables and discussion of Non-GAAP financial measures below.
“Revenue from new business wins is ramping slower than forecasted due to longer implementation cycles. With more than 30 new programs still scheduled for implementation, representing over $100 million of spend, we believe these opportunities will drive stronger growth as we get them up and running,” stated William J. Grubbs, Chief Executive Officer. “The pipeline for new Managed Service Programs remains strong and we expect to have another record year of new business wins.”
First quarter consolidated revenue was $207.6 million, an increase of 6% year-over-year and a decrease of 7% sequentially. Consolidated gross profit margin was 25.7%, down 30 basis points year-over-year and down 20 basis points sequentially. Net loss attributable to common shareholders was $2.0 million compared to net income of $19.0 million in the prior year. The 2017 first quarter included a loss on early extinguishment of debt of $5.0 million, and both periods included gains on derivative liability of $1.6 million for the first quarter of 2017 and $16.4 million for the first quarter of 2016. Diluted EPS was a loss of $0.08 per share compared to income of $0.09 per share in the prior year. Adjusted EBITDA was $6.5 million or 3.1% of revenue, as compared with $8.5 million or 4.3% of revenue in the prior year. Adjusted EPS was $0.05 compared to $0.09 in the prior year and $0.20 in the prior quarter.
Quarterly Business Segment Highlights
Nurse and Allied Staffing
Revenue from Nurse and Allied Staffing was $183.1 million, an increase of 8% year-over-year and a decrease of 6% sequentially. The year-over-year increase in segment revenue was due to growth in volume and improved pricing. Contribution income in this segment was $15.6 million, down from $16.8 million in the prior year. Average field FTEs increased to 7,204 from 6,817 in the prior year. Revenue per FTE per day was $282 compared to $272 in the prior year, reflecting higher average bill rates.
Physician Staffing
Revenue from Physician Staffing decreased 12% year-over-year and 13% sequentially. The year-over-year decrease was primarily due to a decrease in volume. Contribution income was $0.8 million, down from $1.6 million in the prior year. Compared to the prior year, total days filled decreased to 15,036 from 16,842 while revenue per day filled increased to $1,592 from $1,521 due to improved pricing and mix of business.
Other Human Capital Management Services
Revenue from Other Human Capital Management Services decreased 11% year-over-year and 18% sequentially. Contribution income was a loss of $0.4 million, compared to a loss of $0.1 million in the prior year.
Cash Flow and Balance Sheet Highlights
Cash flow provided by operating activities for the current quarter was $1.4 million compared to $2.6 million in the same period of the prior year. At March 31, 2017, the Company had $13.4 million in cash and cash equivalents and $38.2 million of total debt. During the quarter, the Company repaid in full its Convertible Notes by issuing 3,175,584 shares and paying $5.6 million, including $0.6 million for the contractual interest due through the optional conversion date as of June 30, 2017. There were no borrowings drawn on its $100.0 million revolving credit facility, and $22.1 million of letters of credit outstanding, leaving $77.9 million available for borrowings under the revolving credit facility.
Outlook for Second Quarter 2017
| Q2 2017 Range | Year-over-Year | Sequential | ||||||||||
| Change | Change | |||||||||||
| Revenue | $207 million - $212 million | 4% - 6% | 0% - 2% | |||||||||
| Gross profit margin | 26.0% - 26.5% | (150) - (100) bps | 30 - 80 bps | |||||||||
| Adjusted EBITDA | $8 million - $9 million | (28)% - (19)% | 24% - 39% | |||||||||
| Adjusted EPS | $0.08 - $0.10 | $(0.08) - $(0.06) | $0.03 - $0.05 |
The estimates above are based on current management expectations and, as such, are forward-looking and actual results may differ materially. These ranges do not include the potential impact of any future divestitures, mergers, acquisitions or other business combinations, any impairment charges or valuation allowances, any acquisition-related measurement period adjustments, changes in debt structure, or any material legal or restructuring charges.
INVITATION TO CONFERENCE CALL
The Company will hold its quarterly conference call on Thursday, May 4, 2017, at 9:00 A.M. Eastern Time to discuss its first quarter 2017 financial results. This call will be webcast live and can be accessed at the Company's website at www.crosscountryhealthcare.com or by dialing 800-857-6331 from anywhere in the U.S. or by dialing 517-623-4781 from non-U.S. locations - Passcode: Cross Country. A replay of the webcast will be available from May 4th through May 18th at the Company's website and a replay of the conference call will be available by telephone by calling 866-505-9259 from anywhere in the U.S. or 203-369-1883 from non-U.S. locations - Passcode: 2017.
ABOUT CROSS COUNTRY HEALTHCARE
Cross Country Healthcare is a national leader in providing innovative healthcare workforce solutions and staffing services. Our solutions leverage our nearly 40 years of expertise and insight to assist clients in solving complex labor-related challenges while maintaining high quality outcomes. We are dedicated to recruiting and placing highly qualified healthcare professionals in virtually every specialty and area of expertise. With more than 8,000 active contracts, our diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. Through our national staffing teams and network of 74 office locations, we are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. We are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. In addition, we provide both retained and contingent placement services for healthcare executives, physicians, and other healthcare professionals.
Copies of this and other news releases as well as additional information about Cross Country Healthcare can be obtained online at www.crosscountryhealthcare.com. Shareholders and prospective investors can also register to automatically receive the Company's press releases, SEC filings and other notices by e-mail.
NON-GAAP FINANCIAL MEASURES
This press release and accompanying financial statement tables reference non-GAAP financial measures. Such non-GAAP financial measures are provided as additional information and should not be considered substitutes for, or superior to, financial measures calculated in accordance with U.S. GAAP. Such non-GAAP financial measures are provided for consistency and comparability to prior year results; furthermore, management believes they are useful to investors when evaluating the Company's performance as they exclude certain items that management believes are not indicative of the Company's operating performance. Pro forma measures, if applicable, are adjusted to include the results of our acquisitions, and exclude the results of divestments, as if the transactions occurred in the beginning of the periods mentioned. Such non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. The financial statement tables that accompany this press release include a reconciliation of each non-GAAP financial measure to the most directly comparable U.S. GAAP financial measure and a more detailed discussion of each financial measure; as such, the financial statement tables should be read in conjunction with the presentation of these non-GAAP financial measures.
FORWARD LOOKING STATEMENT
In addition to historical information, this press release contains statements relating to our future results (including certain projections and business trends) that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the “safe harbor” created by those sections. Forward-looking statements consist of statements that are predictive in nature, depend upon or refer to future events. Words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, “suggests”, “appears”, “seeks”, “will”, and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following: our ability to attract and retain qualified nurses, physicians and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, demand for the healthcare services we provide, both nationally and in the regions in which we operate, the functioning of our information systems, the effect of cyber security risks and cyber incidents on our business, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, our clients' ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, including our ability to successfully integrate acquired businesses and realize synergies from such acquisitions, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, our ability to successfully defend the Company, its subsidiaries, and its officers and directors on the merits of any lawsuit or determine its potential liability, if any, and other factors set forth in Item 1A. “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2016, and our other Securities and Exchange Commission filings made prior to the date hereof.
Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's opinions only as of the date of this press release. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors' likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements. All references to “we”, “us”, “our”, or “Cross Country” in this press release mean Cross Country Healthcare, Inc. and its subsidiaries.
| Cross Country Healthcare, Inc. | ||||||||||||||
| Consolidated Statements of Operations | ||||||||||||||
| (Unaudited, amounts in thousands, except per share data) | ||||||||||||||
| Three Months Ended | ||||||||||||||
| March 31, | March 31, | December 31, | ||||||||||||
| 2017 | 2016 | 2016 | ||||||||||||
| Revenue from services | $ | 207,573 | $ | 196,583 | $ | 222,523 | ||||||||
| Cost of services | 154,298 | 145,537 | 164,890 | |||||||||||
| Gross profit | 53,275 | 51,046 | 57,633 | |||||||||||
| Operating expenses: | ||||||||||||||
| Selling, general and administrative expenses | 47,236 | 42,933 | 46,290 | |||||||||||
| Bad debt expense | 323 | 249 | 97 | |||||||||||
| Depreciation and amortization | 2,191 | 2,412 | 2,213 | |||||||||||
| Acquisition-related contingent consideration (a) | 270 | 287 | 107 | |||||||||||
| Acquisition and integration costs (b) | — | — | 78 | |||||||||||
| Restructuring costs (c) | — | — | 142 | |||||||||||
| Total operating expenses | 50,020 | 45,881 | 48,927 | |||||||||||
| Income from operations | 3,255 | 5,165 | 8,706 | |||||||||||
| Other expenses (income): | ||||||||||||||
| Interest expense | 1,219 | 1,635 | 1,428 | |||||||||||
| (Gain) loss on derivative liability (d) | (1,581 | ) | (16,436 | ) | 14,165 | |||||||||
| Loss on early extinguishment of debt (e) | 4,969 | — | — | |||||||||||
| Other income, net | — | (17 | ) | (87 | ) | |||||||||
| (Loss) income before income taxes | (1,352 | ) | 19,983 | (6,800 | ) | |||||||||
| Income tax expense | 366 | 797 | 849 | |||||||||||
| Consolidated net (loss) income | (1,718 | ) | 19,186 | (7,649 | ) | |||||||||
| Less: Net income attributable to noncontrolling interest in subsidiary | 292 | 164 | 235 | |||||||||||
| Net (loss) income attributable to common shareholders | $ | (2,010 | ) | $ | 19,022 | $ | (7,884 | ) | ||||||
| Net (loss) income per share attributable to common shareholders - Basic | $ | (0.06 | ) | $ | 0.60 | $ | (0.24 | ) | ||||||
| Net (loss) income per share attributable to common shareholders - Diluted | $ | (0.08 | ) | $ | 0.09 | $ | (0.24 | ) | ||||||
| Weighted average common shares outstanding: | ||||||||||||||
| Basic | 32,872 | 31,956 | 32,263 | |||||||||||
| Diluted (f) | 36,480 | 36,180 | 32,263 | |||||||||||
| Cross Country Healthcare, Inc. | ||||||||||||||
| Reconciliation of Non-GAAP Financial Measures | ||||||||||||||
| (Unaudited, amounts in thousands, except per share data) | ||||||||||||||
| Three Months Ended | ||||||||||||||
| March 31, | March 31, | December 31, | ||||||||||||
| 2017 | 2016 | 2016 | ||||||||||||
| Adjusted EBITDA: (g) | ||||||||||||||
| Net (loss) income attributable to common shareholders | $ | (2,010 | ) | $ | 19,022 | $ | (7,884 | ) | ||||||
| Depreciation and amortization | 2,191 | 2,412 | 2,213 | |||||||||||
| Interest expense | 1,219 | 1,635 | 1,428 | |||||||||||
| Income tax expense | 366 | 797 | 849 | |||||||||||
| Acquisition-related contingent consideration (a) | 270 | 287 | 107 | |||||||||||
| Acquisition and integration costs (b) | — | — | 78 | |||||||||||
| Restructuring costs (c) | — | — | 142 | |||||||||||
| (Gain) loss on derivative liability (d) | (1,581 | ) | (16,436 | ) | 14,165 | |||||||||
| Loss on early extinguishment of debt (e) | 4,969 | — | — | |||||||||||
| Other income, net | — | (17 | ) | (87 | ) | |||||||||
| Equity compensation | 737 | 648 | 765 | |||||||||||
| Net income attributable to noncontrolling interest in subsidiary | 292 | 164 | 235 | |||||||||||
| Adjusted EBITDA (g) | $ | 6,453 | $ | 8,512 | $ | 12,011 | ||||||||
| Adjusted EPS: (h) | ||||||||||||||
| Numerator: | ||||||||||||||
| Net (loss) income attributable to common shareholders | $ | (2,010 | ) | $ | 19,022 | $ | (7,884 | ) | ||||||
| Non-GAAP adjustments - pretax: | ||||||||||||||
| Acquisition-related contingent consideration (a) | 270 | 287 | 107 | |||||||||||
| Acquisition and integration costs (b) | — | — | 78 | |||||||||||
| Restructuring costs (c) | — | — | 142 | |||||||||||
| (Gain) loss on derivative liability (d) (h) | (1,581 | ) | (16,436 | ) | 14,165 | |||||||||
| Loss on early extinguishment of debt (e) | 4,969 | — | — | |||||||||||
| Tax impact of non-GAAP adjustments (i) | — | — | — | |||||||||||
| Adjusted net income attributable to common shareholders - non-GAAP | $ | 1,648 | $ | 2,873 | $ | 6,608 | ||||||||
| Denominator: | ||||||||||||||
| Weighted average common shares - basic, GAAP | 32,872 | 31,956 | 32,263 | |||||||||||
| Dilutive impact of share-based payments (h) | 674 | 703 | 557 | |||||||||||
| Adjusted weighted average common shares - diluted, non-GAAP | 33,546 | 32,659 | 32,820 | |||||||||||
| Reconciliation: (h) | ||||||||||||||
| Diluted EPS, GAAP | $ | (0.08 | ) | $ | 0.09 | $ | (0.24 | ) | ||||||
| Non-GAAP adjustments - pretax: | ||||||||||||||
| Acquisition-related contingent consideration (a) | 0.01 | 0.01 | — | |||||||||||
| Acquisition and integration costs (b) | — | — | — | |||||||||||
| Restructuring costs (c) | — | — | 0.01 | |||||||||||
| (Gain) loss on derivative liability (d) (h) | (0.05 | ) | (0.50 | ) | 0.43 | |||||||||
| Loss on early extinguishment of debt (e) | 0.15 | — | — | |||||||||||
| Tax impact of non-GAAP adjustments (i) | — | — | — | |||||||||||
| Adjustment for change in dilutive shares (h) | 0.02 | 0.49 | — | |||||||||||
| Adjusted EPS, non-GAAP (h) | $ | 0.05 | $ | 0.09 | $ | 0.20 | ||||||||
| Cross Country Healthcare, Inc. | |||||||||
| Consolidated Balance Sheets | |||||||||
| (Unaudited, amounts in thousands) | |||||||||
| March 31, | December 31, | ||||||||
| 2017 | 2016 | ||||||||
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | $ | 13,401 | $ | 20,630 | |||||
| Accounts receivable, net | 161,765 | 173,620 | |||||||
| Prepaid expenses | 5,727 | 6,126 | |||||||
| Insurance recovery receivable | 3,386 | 3,037 | |||||||
| Other current assets | 1,857 | 2,198 | |||||||
| Total current assets | 186,136 | 205,611 | |||||||
| Property and equipment, net | 12,779 | 12,818 | |||||||
| Goodwill, net | 79,648 | 79,648 | |||||||
| Trade names, indefinite-lived | 35,402 | 35,402 | |||||||
| Other intangible assets, net | 35,762 | 36,835 | |||||||
| Other non-current assets | 18,668 | 18,064 | |||||||
| Total assets | $ | 368,395 | $ | 388,378 | |||||
| Liabilities and Stockholders' Equity | |||||||||
| Current liabilities: | |||||||||
| Accounts payable and accrued expenses | $ | 46,606 | $ | 58,837 | |||||
| Accrued employee compensation and benefits | 28,745 | 33,243 | |||||||
| Other current liabilities | 4,546 | 5,012 | |||||||
| Total current liabilities | 79,897 | 97,092 | |||||||
| Long-term debt and capital lease obligations | 36,169 | 84,760 | |||||||
| Non-current deferred tax liabilities | 13,751 | 13,154 | |||||||
| Long-term accrued claims | 29,512 | 28,870 | |||||||
| Contingent consideration | 5,571 | 5,301 | |||||||
| Other long-term liabilities | 7,601 | 7,399 | |||||||
| Total liabilities | 172,501 | 236,576 | |||||||
| Commitments and contingencies | |||||||||
| Stockholders' equity: | |||||||||
| Common stock | 4 | 3 | |||||||
| Additional paid-in capital | 303,115 | 256,570 | |||||||
| Accumulated other comprehensive loss | (1,207 | ) | (1,241 | ) | |||||
| Accumulated deficit | (106,634 | ) | (104,089 | ) | |||||
| Total Cross Country Healthcare, Inc. stockholders' equity | 195,278 | 151,243 | |||||||
| Noncontrolling interest | 616 | 559 | |||||||
| Total stockholders' equity | 195,894 | 151,802 | |||||||
| Total liabilities and stockholders' equity | $ | 368,395 | $ | 388,378 | |||||
| Cross Country Healthcare, Inc. | ||||||||||||||||||||||||||
| Segment Data (j) | ||||||||||||||||||||||||||
| (Unaudited, amounts in thousands) | ||||||||||||||||||||||||||
| Three Months Ended | % Change Fav/(Unfav) | |||||||||||||||||||||||||
| March 31, | % of | March 31, | % of | December 31, | % of | Year-over- | ||||||||||||||||||||
| 2017 | Total | 2016 | Total | 2016 | Total | Year | Sequential | |||||||||||||||||||
| Revenue from services: | ||||||||||||||||||||||||||
| Nurse and Allied Staffing | $ | 183,108 | 88% | $ | 168,765 | 86% | $ | 194,050 | 87% | 8% | (6)% | |||||||||||||||
| Physician Staffing | 21,464 | 10% | 24,453 | 12% | 24,813 | 11% | (12)% | (13)% | ||||||||||||||||||
| Other Human Capital Management Services | 3,001 | 2% | 3,365 | 2% | 3,660 | 2% | (11)% | (18)% | ||||||||||||||||||
| $ | 207,573 | 100% | $ | 196,583 | 100% | $ | 222,523 | 100% | 6% | (7)% | ||||||||||||||||
| Contribution income: (k) | ||||||||||||||||||||||||||
| Nurse and Allied Staffing | $ | 15,622 | $ | 16,790 | $ | 18,115 | (7)% | (14)% | ||||||||||||||||||
| Physician Staffing | 820 | 1,553 | 2,262 | (47)% | (64)% | |||||||||||||||||||||
| Other Human Capital Management Services | (440 | ) | (111 | ) | (339 | ) | (296)% | (30)% | ||||||||||||||||||
| 16,002 | 18,232 | 20,038 | (12)% | (20)% | ||||||||||||||||||||||
| Unallocated corporate overhead (l) | 10,286 | 10,368 | 8,792 | 1% | (17)% | |||||||||||||||||||||
| Depreciation and amortization | 2,191 | 2,412 | 2,213 | 9% | 1% | |||||||||||||||||||||
| Acquisition-related contingent consideration (a) | 270 | 287 | 107 | 6% | (152)% | |||||||||||||||||||||
| Acquisition and integration costs (b) | — | — | 78 | —% | 100% | |||||||||||||||||||||
| Restructuring costs (c) | — | — | 142 | —% | 100% | |||||||||||||||||||||
| Income from operations | $ | 3,255 | $ | 5,165 | $ | 8,706 | (37)% | (63)% | ||||||||||||||||||
| Cross Country Healthcare, Inc. | |||||||||||
| Other Financial Data | |||||||||||
| (Unaudited) | |||||||||||
| Three Months Ended | |||||||||||
| March 31, | March 31, | December 31, | |||||||||
| 2017 | 2016 | 2016 | |||||||||
| Net cash provided by (used in) operating activities (in thousands) | $ | 1,410 | $ | 2,564 | $ | (2,124) | |||||
| Consolidated gross profit margin | 25.7% | 26.0% | 25.9% | ||||||||
|
Nurse and Allied Staffing statistical data: |
|||||||||||
| FTEs (m) | 7,204 | 6,817 | 7,156 | ||||||||
| Average Nurse and Allied Staffing revenue per FTE per day (n) | $ | 282 | $ | 272 | $ | 295 | |||||
|
Physician Staffing statistical data: |
|||||||||||
| Days filled (o) | 15,036 | 16,842 | 14,521 | ||||||||
| Revenue per day filled (p) | $ | 1,592 | $ | 1,521 | $ | 1,599 | |||||
| (a) | Acquisition-related contingent consideration primarily represents the fair value and accretion adjustments to the contingent consideration liabilities for the Mediscan acquisition that closed on October 30, 2015 and the US Resources Healthcare (USR) acquisition that closed on December 1, 2016. | |
| (b) | Acquisition and integration costs are primarily related to due diligence efforts for the USR acquisition. The results of the acquisition have been included in the Company's consolidated statements of operations since its date of acquisition. | |
| (c) | Restructuring costs related to severance and lease consolidations incurred as part of a discrete cost savings initiative. | |
| (d) | (Gain) loss on derivative liability represents the change in the fair value of embedded features of our Convertible Notes up until their repayment. | |
| (e) | Loss on early extinguishment of debt is related to the Company's settlement of its convertible notes on March 17, 2017. | |
| (f) | When applying the if-converted method to our Convertible Notes, 3,521,126 shares are not included in diluted weighted average shares for the three months ended December 31, 2016 because their effect was anti-dilutive. For the three months ended March 31, 2017, 2,934,271 shares (the weighted average shares outstanding through March 17, 2017) were included in diluted weighted average shares. | |
| (g) | Adjusted EBITDA, a non-GAAP (Generally Accepted Accounting Principles) financial measure, is defined as net (loss) income attributable to common shareholders before depreciation, amortization, interest expense, income tax expense, acquisition-related contingent consideration, acquisition and integration costs, restructuring costs, (gain) loss on derivative liability, loss on early extinguishment of debt, other income, net, equity compensation, and includes net income attributable to noncontrolling interest in subsidiary. Adjusted EBITDA should not be considered a measure of financial performance under GAAP. Management presents Adjusted EBITDA because it believes that Adjusted EBITDA is a useful supplement to net income (loss) attributable to common shareholders as an indicator of operating performance. Management uses Adjusted EBITDA for planning purposes and as one performance measure in its annual cash incentive program for certain members of its management team. Adjusted EBITDA, as defined, closely matches the operating measure typically used in the Company's credit facilities in calculating various ratios. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by the Company's consolidated revenue. | |
| (h) | Adjusted EPS, a non-GAAP financial measure, is defined as net (loss) income attributable to common shareholders per diluted share before the diluted EPS impact of acquisition-related contingent consideration, acquisition and integration costs, restructuring costs, (gain) loss on derivative liability, and loss on early extinguishment of debt. Adjusted EPS should not be considered a measure of financial performance under GAAP. Management presents Adjusted EPS because it believes that Adjusted EPS is a useful supplement to its reported EPS as an indicator of operating performance. Management uses Adjusted EPS as one performance measure in its annual cash incentive program for certain members of its management team. Management believes it provides a more useful comparison of the Company's underlying business performance from period to period and is more representative of the future earnings capacity of the Company. For the three months ended December 31, 2016, the adjustments to diluted EPS, GAAP had the effect of converting the net loss to net income. As a result, potentially dilutive shares that were excluded in the diluted EPS, GAAP calculation have been included in the adjusted EPS calculation. When applying the if-converted method for the calculation of diluted EPS, GAAP, the convertible notes were dilutive for the three months ended March 31, 2017 and 2016. Adjusted EPS excludes the effects of the convertible notes that were reported as being dilutive in these periods. | |
| (i) | There is no tax impact for the periods presented due to the Company's full valuation allowance for all reported periods. | |
| (j) | Segment data provided is in accordance with the Segment Reporting Topic of the FASB ASC. | |
| (k) | Contribution income is defined as income from operations before depreciation, amortization, loss on sale of business, acquisition and integration costs, acquisition-related contingent consideration, restructuring costs, impairment charges, and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance. | |
| (l) | Unallocated corporate overhead includes corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives), and public company expense. | |
| (m) | FTEs represent the average number of Nurse and Allied Staffing contract personnel on a full-time equivalent basis. | |
| (n) | Average revenue per FTE per day is calculated by dividing the Nurse and Allied Staffing revenue by the number of days worked in the respective periods. Nurse and Allied Staffing revenue also includes revenue from the permanent placement of nurses. | |
| (o) | Days filled is calculated by dividing the total hours invoiced during the period by 8 hours. | |
| (p) | Revenue per day filled is calculated by dividing revenue invoiced by days filled for the period presented. |
CONTACT:
Cross Country Healthcare, Inc.
William J. Grubbs,
561-237-6202
President & Chief Executive Officer
wgrubbs@crosscountry.com